All Stories

  1. Evaluation of the long-term outcomes of patients with hepatitis delta
  2. Differential Diagnosis of Cytomegalovirus Infection and Disease in HIV/AIDS Patients: A Six-Year Retrospective Analysis
  3. Effect of Mutational Difference on Systemic Immune Inflammation Index in Patients with a Diagnosis of COVID-19
  4. Non-infectious Causes of Blood Transfusion Reactions: A Tertiary Hospital Review
  5. Real-life evaluation of incidence and clinical outcomes of COVID-19 among healthcare workers during pre-vaccination and post-vaccination periods: A cross-sectional impact study
  6. COMPARISON OF CLINICAL OUTCOMES OF CORONAVAC VACCINATED AND UNVACCINATED OLDER ADULTS WITH HOSPITALIZED COVID-19
  7. Evaluation of the impact of the COVID-19 pandemic on nurses
  8. Evaluation of clinical outcomes of vaccinated and unvaccinated patients with hospitalization for COVID-19
  9. Primary partial response with tenofovir monotherapy: two adults and one child
  10. The partial virological response to Tenofovir monotherapy in naïve patients with chronic hepatitis B
  11. Evaluation of Risk Factors for Mortality in Febrile Neutropenia
  12. Agreement Between QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test in Hematopoietic Stem Cell Transplantation Candidates
  13. The Comparison of Cord Blood Omentin-1 Values of Newborns in the Different Birth Weights According to Gestational Age
  14. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients
  15. Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma
  16. The Assessment and Improvement of the Steps in the Endoscope-Reprocessing: A Hospital Report
  17. Practical Staining Method of Well-Unstained Haematological Specimens
  18. Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?
  19. Retrospective Evaluation of Twenty Seven Patients with Diabetic Foot Infection
  20. Tetanus in adults: results of the multicenter ID-IRI study
  21. Is Accurate and Appropriate Endoscope Reprocessing too Hard: An Experience Report
  22. Community-Acquired Pneumonia in Adults: Combination Antibiotic Therapy or Monotherapy? Is Computed Tomography Routinly Perfomed?
  23. Chronic Hepatitis B Reactivation Subsequent to Chronic Hepatitis C Treatment: A Case Report
  24. Common Who, Which, Why, How, What and When Questions of Invasive Fungal Infections
  25. Analysis of Adherence to AllOral HCV Therapy in a Cohort of People who Inject Drugs (PWID)
  26. Etiological causes of pancytopenia: A report of 137 cases
  27. Antimicrobial Resistance or Increased Antimicrobial Resistance Rates Which One is Reality?
  28. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
  29. Yesterday, Today and Tomorrow of Mycology
  30. Primary or Secondary Antifungal Prophylaxis in Resource-limited Settings
  31. Is iron treatment related to weight gain in female patients with iron deficiency anemia?
  32. The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis
  33. A cross-sectional evaluation of home health service in patients with chronic neurologic diseases in a province of Turkey
  34. Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness
  35. Hepatosplenic candidiasis in patient with acute leukemia
  36. A case with acute myeloid leukemia and hepatosplenic Candida parapsilosis
  37. An Acute Leukemia Case with B/T-ALL Phenotypes
  38. A Case with Pancytopenia and Autoimmune Hemolytic Anemia due to Vitamin B12 Deficiency
  39. Hyperammonemia Associated Encephalopathy in Two Cases with Hematological Malignancy
  40. Is Timely and Appropriate Antifungal Drug Enough for Survival of Adult Cases with Candidaemia? Five-year Experience
  41. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies
  42. Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
  43. Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report
  44. Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?
  45. Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
  46. Community-acquired intracranial suppurative infections: 15-year report
  47. Community-acquired intracranial suppurative infections: A 15-year report
  48. Healthcare Associated Infections: Are Medical Staff Always Guilty? What is the Role of Patients?
  49. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies
  50. Money and transmission of bacteria
  51. Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience
  52. A Case of Persistent Urinary Schistosomiasis Transmitted Through the Lake Malawi
  53. Blood and Body Fluid Exposures in Health-Care Settings: Risk Reduction Practices and Postexposure Prophylaxis for Health-Care Workers
  54. Risk factors for drug resistant bacterial infections: Hospital based study
  55. Does antimicrobial use increase the rate of antimicrobial resistance? A one year experience
  56. Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
  57. Pulmonary involvement of Brucellosis: a report of six cases
  58. Bacterial Etiology of Early- and Late-Onset Ventilator-Associated Pneumonia as Detected With Gram Stain, Endotracheal Aspirate, and Mini-BAL Cultures
  59. Extended-Spectrum β-Lactamase Production Rates of Klebsiella spp. and Escherichia coli Strains Isolated From Infections and Fecal Samples of Healthy People